The effects of frusemide on racing times of Standardbred pacers.
Authors: Soma L R, Birks E K, Uboh C E, May L, Teleis D, Martini J
Journal: Equine veterinary journal
Summary
# Editorial Summary This analysis of 788 Standardbred pacers across 8378 races at a single facility examined whether pre-race intravenous frusemide administration—given 4 hours before racing to horses with exercise-induced pulmonary haemorrhage—altered performance times. Frusemide produced a statistically significant reduction in racing times of 0.67 seconds overall (P<0.00001), with sex-specific improvements of 0.46 seconds in horses, 0.31 seconds in geldings, and 0.74 seconds in mares; younger animals showed the most pronounced effect, whilst the performance benefit diminished progressively with age despite older pacers receiving the drug more frequently. Notably, pre-race venous acid-base status—measured in 2729 competing animals and used to regulate frusemide eligibility under Pennsylvania racing rules (base excess thresholds of >10 and >12 mmol/l)—showed no significant relationship to racing times, nor did pre-race values correlate with post-race acid-base measurements. For practitioners, these findings underscore that whilst frusemide demonstrably enhances racing performance in younger pacers, the mechanism may be independent of acid-base buffering capacity, suggesting alternative physiological pathways (such as reduced pulmonary oedema or improved oxygen dynamics) warrant investigation; moreover, current acid-base screening protocols may not effectively stratify which animals would benefit most from pre-race intervention.
Read the full abstract on PubMed
Practical Takeaways
- •Frusemide administration for EIPH management in Standardbred pacers produces measurable performance improvements, with younger horses benefiting more than older ones
- •Regulatory acid-base thresholds (>10 mmol/l without frusemide, >12 mmol/l with frusemide) do not predict racing performance in this population
- •Consider that frusemide use patterns may reflect regulatory oversight rather than clinical need, as older horses received it more frequently despite showing diminished benefit
Key Findings
- •Prerace frusemide administration significantly decreased racing times by 0.67 seconds overall (P<0.00001)
- •Horses, geldings, and females ran 0.46, 0.31, and 0.74 seconds faster respectively with prerace frusemide
- •The performance-enhancing effect of frusemide was most pronounced in younger pacers and decreased with age
- •Prerace venous acid-base levels were not significantly related to racing times, and pre- and postrace acid-base status showed no correlation